锦欣生殖（01951）于2026年3月27日披露回购股份事宜。公司当日于香港联交所场内回购约3,517,500股，约占已发行股本0.13%。回购价格介乎每股2.26港元至2.31港元，总金额约8,047,336.50港元。
根据公告，公司回购授权由股东于2025年6月26日通过，授权总数为274,470,604股。截至该日，公司已累计回购43,179,500股，占购回授权当日公司已发行股本1.5732%。本次回购股份尚未注销，变动后公司已发行股本仍维持在2,744,706,043股，库存股数量为13,000,000股。
公司表示，回购事宜已遵守上市规则及相关法律法规。公告由董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.